Muscle relaxants for out-patient procedures

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Outpatient anesthesia requires rapid muscle relaxation for endotracheal intubation and a short duration of effect.
• Spontaneous reversal of muscle relaxants is preferred for outpatient procedures to minimize recovery time.

Purpose of the Study:

• To evaluate the efficacy and safety of low-dose short-acting muscle relaxants (vecuronium and atracurium) for outpatient anesthesia.
• To determine the onset and duration of action, and the time to spontaneous reversal for these agents.

Main Methods:

• Administration of low doses of vecuronium (0.045 mg/kg) or atracurium (0.2 mg/kg) for outpatient anesthesia.
• Monitoring the time required for endotracheal intubation and the duration of clinical muscle relaxation.
• Assessing the time for spontaneous reversal of neuromuscular blockade.

Main Results:

• Low doses of vecuronium and atracurium provide adequate muscle relaxation for endotracheal intubation after a short delay (5-6 minutes).
• Clinical muscle relaxation lasts for the desired 15-20 minutes.
• Spontaneous reversal of neuromuscular blockade is achieved within 20-30 minutes post-administration.

Conclusions:

• Low-dose vecuronium and atracurium are suitable for outpatient anesthesia, meeting the requirements for short-acting muscle relaxation and spontaneous reversal.
• Careful dose selection is crucial to balance the onset of action and duration of effect.
• Potentiation of relaxation with inhalational agents is not recommended to ensure predictable recovery.